{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:57:47Z","timestamp":1791082667531,"version":"4.1.0"},"reference-count":48,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2014,3,5]],"date-time":"2014-03-05T00:00:00Z","timestamp":1393977600000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J cachexia sarcopenia muscle"],"published-print":{"date-parts":[[2014,3]]},"abstract":"<jats:sec><jats:label\/><jats:p>This article highlights preclinical and clinical studies in the field of wasting disorders that were presented at the 7th Cachexia Conference held in Kobe, Japan, in December 2013. This year, the main topics were the development of new methods and new biomarkers in the field of cachexia and wasting disorders with particular focus on inflammatory pathways, growth differentiation factor\u201015, myostatin, the ubiquitin proteasome\u2010dependent pathway, valosin and the regulation of ubiquitin\u2010specific protease 19 that is involved in the differentiation of myogenin and myosin heavy chain. This article presents highlights from the development of drugs that have shown potential in the treatment of wasting disorders, particularly the ghrelin receptor agonist anamorelin, the myostatin antagonist REGN1033, the selective androgen receptor modulators enobosarm and TEI\u2010E0001, and the anabolic catabolic transforming agent espindolol. In addition, novel data on the prevalence and detection methods of muscle wasting\/sarcopenia are presented, including the D3\u2010creatine dilution method and several new biomarkers.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s13539-014-0136-z","type":"journal-article","created":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T11:14:04Z","timestamp":1393931644000},"page":"27-34","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Highlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategies"],"prefix":"10.1002","volume":"5","author":[{"given":"Nicole","family":"Ebner","sequence":"first","affiliation":[{"name":"Applied Cachexia Research, Department of Cardiology Charit\u00e9 Medical School, Campus Virchow-Klinikum  Augustenburger Platz 1 13353 Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Steinbeck","sequence":"additional","affiliation":[{"name":"Applied Cachexia Research, Department of Cardiology Charit\u00e9 Medical School, Campus Virchow-Klinikum  Augustenburger Platz 1 13353 Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Doehner","sequence":"additional","affiliation":[{"name":"Applied Cachexia Research, Department of Cardiology Charit\u00e9 Medical School, Campus Virchow-Klinikum  Augustenburger Platz 1 13353 Berlin"},{"name":"Centre for Stroke Research Berlin Charit\u00e9 Medical School  Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[{"name":"Applied Cachexia Research, Department of Cardiology Charit\u00e9 Medical School, Campus Virchow-Klinikum  Augustenburger Platz 1 13353 Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"von Haehling","sequence":"additional","affiliation":[{"name":"Applied Cachexia Research, Department of Cardiology Charit\u00e9 Medical School, Campus Virchow-Klinikum  Augustenburger Platz 1 13353 Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,3,5]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2008.06.013"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2013.06.024"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-012-0061-y"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2013.04.025"},{"key":"e_1_2_8_6_1","first-page":"295","article-title":"Acute endotoxaemia in humans increases muscle PDK4 protein expression and impairs nutrient\u2010mediated increases in muscle PDC activity and whole\u2010body glucose disposal","volume":"4","author":"Constantin-Teodosiu D","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_7_1","first-page":"295","article-title":"Inhibition of RANK\/RANKL pathway greatly improves SERCA activity and force production in atrophic and dystrophic skeletal muscles","volume":"4","author":"Dumont N","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_8_1","first-page":"295","article-title":"Growth differentiating factor-15 (GDF-15) induces anorexia and cachexia in mice: a novel pathway for cachexia","volume":"4","author":"Lerner L","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055174"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2013.03.014"},{"key":"e_1_2_8_11_1","first-page":"295","article-title":"Increased expression of protein catabolism and ActRIIB pathway in a non\u2010human primate (NHP) radiation\u2010induced cachexia model","volume":"4","author":"Cui W","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_12_1","first-page":"295","article-title":"The p97\/VCP ATPase is critical in muscle atrophy and for the accelerated degradation of most muscle proteins","volume":"4","author":"Piccirillo R","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_13_1","first-page":"295","article-title":"USP19 regulates differentiation of muscle cells","volume":"4","author":"Wiles B","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_14_1","first-page":"295","article-title":"Identification and characterization of USP19 inhibitors","volume":"4","author":"Segawa K","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_15_1","first-page":"295","article-title":"PGC-1\u03b1 counteracts cancer\u2010induced muscle wasting in female mice","volume":"4","author":"Costelli P","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_16_1","first-page":"295","article-title":"Higher prevalence of sarcopenia in older adults with type 2 diabetes","volume":"4","author":"Kim KS","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_17_1","first-page":"295","article-title":"Sarcopenia in Ukrainian women of different age","volume":"4","author":"Povoroznyuk V","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2013.08.015"},{"key":"e_1_2_8_19_1","first-page":"295","article-title":"Prevalence of sarcopenia in community\u2010dwelling Japanese older adults","volume":"4","author":"Yamada M","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_20_1","first-page":"1","article-title":"The application of segmental bioelectrical impedance spectroscopy in assessment of sarcopenia in elderly","volume":"5","author":"Yamada Y","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_21_1","first-page":"295","article-title":"The deuterium oxide (D2O) stable isotope tracer is a powerful tool for monitoring short\u2010term changes in skeletal muscle protein synthesis at rest and in response to exercise","volume":"4","author":"Wilkinson DJ","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_22_1","first-page":"295","article-title":"Fat\u2010free and fat mass can be measured with D2O dilution and gas chromatography\u2013tandem mass spectrometry","volume":"4","author":"Walker DK","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-013-0110-1"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2012.03.002"},{"key":"e_1_2_8_25_1","first-page":"1","article-title":"C-terminal agrin fragment as a marker of muscle wasting in patients after acute stroke during early rehabilitation","volume":"5","author":"Scherbakov N","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-010-0013-3"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2013.08.008"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs381"},{"key":"e_1_2_8_29_1","first-page":"1","article-title":"C-terminal agrin fragment as a novel diagnostic marker for muscle wasting in patients with chronic heart failure: results from the Studies Investigating Co\u2010morbidities Aggravating Heart Failure","volume":"5","author":"Steinbeck L","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_30_1","first-page":"4","article-title":"Rikkunshito, a Japasese Kampo medicine, ameliorates anorexia and muscle wasting via ghrelin secretion in mice with bleomycin\u2010induced pulmonary fibrosis","volume":"5","author":"Mogami S","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_31_1","first-page":"4","article-title":"A novel cachexia rat model with possible ghrelin resistance generated by implantation of a human gastric cancer\u2010derived 85As2 cell line: a traditional Japanese medicine rikkunshito ameliorates cachexia symptoms by potentiation of ghrelin receptor\u2010mediated signaling","volume":"5","author":"Terawaki K","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_32_1","first-page":"295","article-title":"Rikkunshito, Japanese herbal medicine reduces urocortin1-induced anorexia and Fos expression in the central nerve nuclei of autonomic nerves","volume":"4","author":"Yakabi K","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_33_1","first-page":"295","article-title":"Effects of oral administration of Rikkunshito on cisplatin\u2010induced anorexia in rats","volume":"4","author":"Ueta Y","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_34_1","first-page":"6","article-title":"Gender differences in the mechanism of action of rikkunshito on the improvement in food intake after exposure to a novel environmental stress in aged mice","volume":"5","author":"Yamada C","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_35_1","first-page":"295","article-title":"Ghrelin prevents cancer\u2010related muscle wasting through GHSR-independent regulation of myostatin and p38","volume":"4","author":"Chen J","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_36_1","first-page":"295","article-title":"Individually dose\u2010optimized phase I\u2013II study with natural ghrelin in advanced cancer patients with cachexia","volume":"4","author":"Blum D","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_37_1","first-page":"295","article-title":"Efficacy and safety results from a phase II study of anamorelin HCl, a ghrelin receptor agonist, in NSCLC patients","volume":"4","author":"Temel J","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_38_1","first-page":"295","article-title":"Anamorelin HCl for the treatment of anorexia\u2013cachexia in lung cancer: study design and baseline characteristics of patients in the phase III clinical trial ROMANA 2 (HT-ANAM-302)","volume":"4","author":"Abernethy A","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_39_1","first-page":"6","article-title":"Novel beef as a protein source for patients with masticatory disturbance","volume":"5","author":"Takei R","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_40_1","first-page":"6","article-title":"Krill oil supplement improves blood lipids status in cachectic advanced cancer patient","volume":"5","author":"Serpe R","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_41_1","first-page":"295","article-title":"Impact of a two\u2010drug combination regimen for cancer\u2010related cachexia on nutritional, anabolic\/metabolic, physical activity, anti\u2010inflammatory and quality of life variables","volume":"4","author":"Madeddu C","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_42_1","first-page":"295","article-title":"Efficacy of REGN1033, a fully human anti\u2010myostatin antagonist antibody, in rodent muscle function","volume":"4","author":"Bauerlein R","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-011-0034-6"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70055-X"},{"key":"e_1_2_8_45_1","first-page":"295","article-title":"Anabolic effect of a novel long\u2010acting SARM in rat ORX model","volume":"4","author":"Takagi K","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-014-0153-y"},{"key":"e_1_2_8_47_1","first-page":"3","article-title":"MT-102 a new anabolic catabolic transforming agent improves heart function in a rat model of cancer cachexia","volume":"5","author":"Musolino V","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-011-0046-2"},{"key":"e_1_2_8_49_1","first-page":"4","article-title":"Beta\u2010blocker for the treatment of cancer cachexia: are they all equal?","volume":"5","author":"Palus S","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["Journal of Cachexia, Sarcopenia and Muscle"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1007%2Fs13539-014-0136-z","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s13539-014-0136-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T06:37:25Z","timestamp":1698475045000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/s13539-014-0136-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["10.1007\/s13539-014-0136-z"],"URL":"https:\/\/doi.org\/10.1007\/s13539-014-0136-z","archive":["Portico"],"relation":{},"ISSN":["2190-5991","2190-6009"],"issn-type":[{"value":"2190-5991","type":"print"},{"value":"2190-6009","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"2014-01-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-01-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-03-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}